Get the latest news and updates
As CEO of Sangamo, a pioneer in genomic medicine, Sandy Macrae's mission is advancing genomic medicine to fundamentally change how diseases are treated: not only managing, but curing, genetic diseases. Dr. Macrae has twenty years of experience in the pharmaceutical industry, most recently serving as the Global Medical Officer of Takeda Pharmaceuticals, where he established and led the Global Medical Office, which encompasses medical affairs, regulatory affairs, pharmacovigilance, outcomes research and epidemiology, quantitative sciences and knowledge and informatics. Dr. Macrae received his B.S. in pharmacology and his M.B., Ch.B. with honors from Glasgow University. He is a member of the Royal College of Physicians. Dr. Macrae also earned his Ph.D. in molecular genomics at King’s College, Cambridge.